(Q26747221)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

review article

2 references

12 September 2020

Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

focal segmental glomerulosclerosis

2 April 2020

main subject

5 references

13 March 2019

20 November 2019

27 November 2019

29 May 2020

12 September 2020

4 references

13 March 2019

20 November 2019

27 November 2019

12 September 2020

1 reference

20 November 2019

1 reference

27 November 2019

1 reference

12 September 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Lorenz Sellin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Eva Königshausen

series ordinal

1

0 references

Lorenz Sellin

series ordinal

2

0 references

language of work or name

English

0 references

publication date

21 April 2016

6 references

13 March 2019

20 November 2019

27 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

29 May 2020

12 September 2020

BioMed Research International

6 references

13 March 2019

20 November 2019

27 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

12 September 2020

2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

3765608

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

2 April 2020

copyright license

4 references

13 March 2019

20 November 2019

27 November 2019

on focus list of Wikimedia project

12 September 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

CD40/CD40L signaling and its implication in health and disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

suPAR: the molecular crystal ball

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Soluble Urokinase Receptor and Chronic Kidney Disease.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Causes and pathogenesis of focal segmental glomerulosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Abatacept in B7-1-positive proteinuric kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Circulating suPAR in two cohorts of primary FSGS.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Focal segmental glomerulosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

US Renal Data System 2010 Annual Data Report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Regulation of cell signalling by uPAR.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Trends in the epidemiology of focal segmental glomerulosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

uPAR: a versatile signalling orchestrator

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: re-analysis of published case-reports and case-series

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

Proteinuria after injection of human focal segmental glomerulosclerosis factor

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Proteinuria in rats induced by serum from patients with collapsing glomerulopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Transmission of glomerular permeability factor from a mother to her child

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Modification of kidney barrier function by the urokinase receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Reassessing the Reassessment of suPAR in Glomerular Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Abatacept in B7-1-positive proteinuric kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F3765608

Pathologic classification of focal segmental glomerulosclerosis: a working proposal

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4856884

The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis

28 November 2018

1 reference

12 December 2020

Serum-soluble urokinase receptor concentration in primary FSGS

1 reference

12 December 2020

"The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma

1 reference

12 December 2020

Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis

1 reference

12 December 2020

Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation

1 reference

12 December 2020

A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease

1 reference

12 December 2020

Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease

1 reference

12 December 2020

Urokinase receptor. An activation antigen in human T lymphocytes

1 reference

12 December 2020

Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients

1 reference

12 December 2020

Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

1 reference

12 December 2020

Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis

1 reference

12 December 2020

Resolution of recurrent focal segmental glomerulosclerosis after retransplantation

1 reference

12 December 2020

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

1 reference

12 December 2020

Usefulness of Soluble Urokinase Plasminogen Activator Receptor to Predict Repeat Myocardial Infarction and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention

1 reference

12 December 2020

Measurement of albumin reflection coefficient with isolated rat glomeruli

1 reference

12 December 2020

The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils

1 reference

12 December 2020

Partial remission of resistant nephrotic syndrome after oral galactose therapy

1 reference

12 December 2020

Identifiers

DOI

10.1155/2016/3765608

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27200372%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

2 references